Results 181 to 190 of about 18,762 (211)

Machine learning-based prediction of response to Janus kinase inhibitors in patients with rheumatoid arthritis using clinical data. [PDF]

Front Immunol
Lee YJ, Choi G, Yeo J, Baek J, Choi H, Kim M, Kim YG, Kim BY, Koo J.   +8 more
europepmc   +1 more source

A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes. [PDF]

J Clin Med
Lambiase S, Cavalloro D, Cioni A, Matteini E, Artosi F, Poscente F, Belardi R, Terrinoni A, Bernardini S, Bianchi L, Campione E, Diluvio L.   +11 more
europepmc   +1 more source

Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study. [PDF]

Rheumatol Ther
Alten R, Östör A, Edwards CJ, Smolen JS, Haladyj E, Ng KJ, Ogwu S, Kaneko Y.   +7 more
europepmc   +1 more source

A Population Pharmacokinetic and Exposure-Response Analysis for Baricitinib in Pediatric Patients with Atopic Dermatitis. [PDF]

Clin Pharmacokinet
Decker RL, Ernest CS, Radtke DB, Prakash A, Zhang X.   +4 more
europepmc   +1 more source

Pretreatment Cytokine Signatures as Candidate Biomarkers for JAK Inhibitor Response in Anti-MDA5 Dermatomyositis-Related Interstitial Lung Disease: A Pilot Study. [PDF]

ACR Open Rheumatol
Matsuo H, Koga T, Shimizu T, Ide H, Koto S, Kojima K, Fujita Y, Okamoto M, Takatani A, Suzuki T, Matsushita Y, Kawakami A.   +11 more
europepmc   +1 more source

Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study. [PDF]

Cureus
Bland K, Jubber A, Ganguly S, Moorthy A.
europepmc   +1 more source

Cutaneous Lymphoma Associated with JAK Inhibitors: A Pharmacovigilance Analysis of the FAERS Database and Literature Review. [PDF]

Acta Derm Venereol
Lu L, Feng J, He H, Peng Y, Zhang S, Yang L, Liu Y, Wang T.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Baricitinib

Reactions Weekly
  +19 more sources

Baricitinib

Reactions Weekly, 2023
  +14 more sources